{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:21:44Z","timestamp":1787808104803,"version":"build-2784847793"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam Bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2023\/R\/1444"],"award-info":[{"award-number":["PSAU\/2023\/R\/1444"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Minoxidil, originally developed as an antihypertensive medication, has evolved into a versatile therapeutic agent within dermatology, notably for its effectiveness in promoting hair growth. Despite its widespread use, understanding its precise mechanism of action remains a challenge. This paper addresses this gap by providing a comprehensive review of pharmacological properties, action mechanisms, clinical effectiveness and side effects associated with topical minoxidil. Furthermore, it highlights emerging trends and applications, including its role in treating androgenetic alopecia, its potential for alopecia areata management and its utilization in combination therapies. Additionally, this paper explores novel applications in scar treatment and wound healing. By synthesizing current knowledge and insights, this review adds clarity to the diverse applications of minoxidil, providing valuable guidance for clinicians and researchers aiming to optimize its therapeutic use in dermatology.<\/jats:p>","DOI":"10.1002\/ski2.472","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T01:25:34Z","timestamp":1732497934000},"source":"Crossref","is-referenced-by-count":12,"title":["Applications and Efficacy of Minoxidil in Dermatology"],"prefix":"10.1093","volume":"4","author":[{"given":"Ramadan S.","family":"Hussein","sequence":"first","affiliation":[{"name":"Department of Dermatology, College of Medicine, Prince Sattam Bin Abdulaziz University , Al-Kharj ,","place":["Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman Bin","family":"Dayel","sequence":"additional","affiliation":[{"name":"Department of Dermatology, College of Medicine, Prince Sattam Bin Abdulaziz University , Al-Kharj ,","place":["Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othman","family":"Abahussein","sequence":"additional","affiliation":[{"name":"Department of Dermatology, College of Medicine, Prince Sattam Bin Abdulaziz University , Al-Kharj ,","place":["Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer Ali","family":"El-Sherbiny","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University , Al-Kharj ,","place":["Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,24]]},"reference":[{"issue":"3","key":"2025112606022239300_ski2472-bib-0001","first-page":"185","article-title":"Topical minoxidil: systematic review and meta-analysis of its efficacy in alopecia","volume":"13","author":"Gupta","year":"2015","journal-title":"Skinmed"},{"issue":"3","key":"2025112606022239300_ski2472-bib-0002","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3390\/ijms19030691","article-title":"Minoxidil promotes hair growth through stimulation of growth factor release from adipose-derived stem cells","volume":"19","author":"Choi","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2025112606022239300_ski2472-bib-0003","first-page":"155","article-title":"The efficacy of topical minoxidil for non-scarring alopecia: a systematic review","volume":"18","author":"Sung","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"2025112606022239300_ski2472-bib-0004","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.matbio.2005.04.002","article-title":"Minoxidil exerts different inhibitory effects on gene expression of lysyl hydroxylase 1, 2, and 3: implications for collagen cross-linking and treatment of fibrosis","volume":"24","author":"Zuurmond","year":"2005","journal-title":"Matrix Biol"},{"issue":"2","key":"2025112606022239300_ski2472-bib-0005","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2133.2004.05785.x","article-title":"Minoxidil: mechanisms of action on hair growth","volume":"150","author":"Messenger","year":"2004","journal-title":"Br J Dermatol"},{"issue":"1","key":"2025112606022239300_ski2472-bib-0006","first-page":"229","article-title":"Synthesis and vasorelaxant effect of 9-aryl-1,8-acridinediones as potassium channel openers in isolated rat aorta","volume":"11","author":"Imenshahidi","year":"2012","journal-title":"Iran J Pharm Res (IJPR)"},{"issue":"3","key":"2025112606022239300_ski2472-bib-0007","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1046\/j.1365-2133.1998.02115.x","article-title":"Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells","volume":"138","author":"Lachgar","year":"1998","journal-title":"Br J Dermatol"},{"issue":"4","key":"2025112606022239300_ski2472-bib-0008","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jaad.2008.07.001","article-title":"Medical treatments for male and female pattern hair loss","volume":"59","author":"Rogers","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2025112606022239300_ski2472-bib-0009","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2174\/187221312800166859","article-title":"Minoxidil use in dermatology, side effects and recent patents","volume":"6","author":"Rossi","year":"2012","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"issue":"Suppl 2","key":"2025112606022239300_ski2472-bib-0010","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1097\/00005344-198000022-00002","article-title":"Pharmacology and pharmacokinetics of minoxidil","volume":"2","author":"Lowenthal","year":"1980","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"2025112606022239300_ski2472-bib-0011","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4103\/0019-5154.84714","article-title":"Liquid formulation of minoxidil versus its foam formulation","volume":"56","author":"Purnak","year":"2011","journal-title":"Indian J Dermatol"},{"issue":"1","key":"2025112606022239300_ski2472-bib-0012","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jaad.2017.02.054","article-title":"The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis","volume":"77","author":"Adil","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2025112606022239300_ski2472-bib-0013","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0190-9622(90)70089-z","article-title":"Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil","volume":"22","author":"Olsen","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2025112606022239300_ski2472-bib-0014","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/ijd.13838","article-title":"Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone","volume":"57","author":"Sinclair","year":"2018","journal-title":"Int J Dermatol"},{"issue":"3 Pt 2","key":"2025112606022239300_ski2472-bib-0015","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/s0190-9622(87)70096-6","article-title":"Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy","volume":"16","author":"Price","year":"1987","journal-title":"J Am Acad Dermatol"},{"issue":"3 Pt 2","key":"2025112606022239300_ski2472-bib-0016","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/s0190-9622(87)80003-8","article-title":"Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata","volume":"16","author":"Fiedler-Weiss","year":"1987","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"2025112606022239300_ski2472-bib-0017","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1001\/archderm.1987.01660350088019","article-title":"Evaluation of oral minoxidil in the treatment of alopecia areata","volume":"123","author":"Fiedler-Weiss","year":"1987","journal-title":"Arch Dermatol"},{"issue":"1","key":"2025112606022239300_ski2472-bib-0018","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaad.2004.05.014","article-title":"Frontal fibrosing alopecia in postmenopausal women","volume":"52","author":"Tosti","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2025112606022239300_ski2472-bib-0019","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s40257-016-0230-4","article-title":"Treating alopecia areata: current practices versus new directions","volume":"18","author":"Gupta","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"2025112606022239300_ski2472-bib-0020","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1046\/j.1365-2230.2002.01080.x","article-title":"Telogen effluvium","volume":"27","author":"Harrison","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"2025112606022239300_ski2472-bib-0021","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.11775.1","article-title":"Treatment of chronic telogen effluvium with oral minoxidil: a retrospective study","volume":"6","author":"Perera","year":"2017","journal-title":"F1000Res"},{"issue":"3","key":"2025112606022239300_ski2472-bib-0022","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1468-3083.2006.01933.x","article-title":"Traction alopecia: 2% topical minoxidil shows promise. Report of two cases","volume":"21","author":"Khumalo","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"2025112606022239300_ski2472-bib-0023","first-page":"1153","article-title":"Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil","volume":"30","author":"McCoy","year":"2016","journal-title":"J Biol Regul Homeost Agents"},{"issue":"4","key":"2025112606022239300_ski2472-bib-0024","doi-asserted-by":"publisher","first-page":"314","DOI":"10.5582\/irdr.2016.01065","article-title":"Frontal fibrosing alopecia treatment options","volume":"5","author":"Fertig","year":"2016","journal-title":"Intractable Rare Dis Res"},{"issue":"4","key":"2025112606022239300_ski2472-bib-0025","first-page":"937","article-title":"The effect of topical minoxidil treatment on follicular sulfotransferase enzymatic activity","volume":"32","author":"Goren","year":"2018","journal-title":"J Biol Regul Homeost Agents"},{"issue":"3","key":"2025112606022239300_ski2472-bib-0026","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/dth.12111","article-title":"Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia","volume":"27","author":"Goren","year":"2014","journal-title":"Dermatol Ther"},{"issue":"5","key":"2025112606022239300_ski2472-bib-0027","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1111\/jocd.14895","article-title":"Topical finasteride for male and female pattern hair loss: is it a safe and effective alternative?","volume":"21","author":"Gupta","year":"2022","journal-title":"J Cosmet Dermatol"},{"issue":"12","key":"2025112606022239300_ski2472-bib-0028","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1111\/jdv.15171","article-title":"A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia","volume":"32","author":"Suchonwanit","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"2025112606022239300_ski2472-bib-0029","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1001\/archderm.1992.01680210045005","article-title":"Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata","volume":"128","author":"Olsen","year":"1992","journal-title":"Arch Dermatol"},{"issue":"1","key":"2025112606022239300_ski2472-bib-0030","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/dss.0000000000001198","article-title":"Platelet-rich plasma in combination with 5% minoxidil topical solution and 1 mg oral finasteride for the treatment of androgenetic alopecia: a randomized placebo-controlled, double-blind, half-head study","volume":"44","author":"Alves","year":"2018","journal-title":"Dermatol Surg"},{"issue":"18","key":"2025112606022239300_ski2472-bib-0031","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186516","article-title":"Comparative evaluation of the clinical efficacy of PRP-therapy, minoxidil, and their combination with immunohistochemical study of the dynamics of cell proliferation in the treatment of men with androgenetic alopecia","volume":"21","author":"Pakhomova","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2025112606022239300_ski2472-bib-0032","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1080\/14712598.2020.1797676","article-title":"A randomized blinded retrospective study: the combined use of micro-needling technique, low-level laser therapy and autologous non-activated platelet-rich plasma improves hair re-growth in patients with androgenic alopecia","volume":"20","author":"Gentile","year":"2020","journal-title":"Expet Opin Biol Ther"},{"issue":"1","key":"2025112606022239300_ski2472-bib-0033","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/ijt.ijt_75_16","article-title":"A comparative study of microneedling with platelet-rich plasma plus topical minoxidil (5%) and topical minoxidil (5%) alone in androgenetic alopecia","volume":"9","author":"Shah","year":"2017","journal-title":"Int J Trichol"},{"issue":"2","key":"2025112606022239300_ski2472-bib-0034","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4103\/JCAS.JCAS_33_20","article-title":"Platelet-rich plasma with microneedling in androgenetic alopecia: study of efficacy of the treatment and the number of sessions required","volume":"14","author":"Yepuri","year":"2021","journal-title":"J Cutan Aesthetic Surg"},{"issue":"5","key":"2025112606022239300_ski2472-bib-0035","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1111\/jocd.12864","article-title":"Platelet-rich plasma and microneedling improves hair growth in patients of androgenetic alopecia when used as an adjuvant to minoxidil","volume":"18","author":"Jha","year":"2019","journal-title":"J Cosmet Dermatol"},{"issue":"Pt 1","key":"2025112606022239300_ski2472-bib-0036","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/bj2830051","article-title":"Minoxidil specifically decreases the expression of lysine hydroxylase in cultured human skin fibroblasts","volume":"283","author":"Hautala","year":"1992","journal-title":"Biochem J"},{"issue":"3","key":"2025112606022239300_ski2472-bib-0037","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2133.1991.Tb14743.x","article-title":"The metabolism of fibroblasts from normal and fibrotic skin is inhibited by minoxidil in vitro","volume":"125","author":"Priestley","year":"1991","journal-title":"Br J Dermatol"},{"issue":"5","key":"2025112606022239300_ski2472-bib-0038","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1080\/03008207.2020.1816992","article-title":"Minoxidil decreases collagen I deposition and tissue-like contraction in clubfoot-derived cells: a way to improve conservative treatment of relapsed clubfoot","volume":"62","author":"Knitlova","year":"2021","journal-title":"Connect Tissue Res"},{"issue":"3","key":"2025112606022239300_ski2472-bib-0039","doi-asserted-by":"publisher","first-page":"54","DOI":"10.21103\/article13(3)_ra5","article-title":"Acne scar management: minoxidil as a promising approach or a mirage?","volume":"13","author":"Ramadan","year":"2023","journal-title":"Int J Biomed"},{"issue":"4","key":"2025112606022239300_ski2472-bib-0040","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0738-081x(88)90080-6","article-title":"Effects of minoxidil on human skin fibroblasts in culture","volume":"6","author":"Pinnell","year":"1988","journal-title":"Clin Dermatol"},{"issue":"1","key":"2025112606022239300_ski2472-bib-0041","first-page":"243","article-title":"Effects of minoxidil gel on burn wound healing in rats","volume":"13","author":"Khazaeli","year":"2014","journal-title":"Iran J Pharm Res (IJPR)"},{"issue":"2","key":"2025112606022239300_ski2472-bib-0042","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1067\/mjd.2002.119104","article-title":"Allergic contact dermatitis to topical minoxidil solution: etiology and treatment","volume":"46","author":"Friedman","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2025112606022239300_ski2472-bib-0043","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1046\/j.1468-3083.2003.00621.x","article-title":"Hypertrichosis in females applying minoxidil topical solution and in normal controls","volume":"17","author":"Dawber","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2025112606022239300_ski2472-bib-0044","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1365-2133.1997.tb08760.x","article-title":"Diffuse hypertrichosis during treatment with 5% topical minoxidil","volume":"136","author":"Peluso","year":"1997","journal-title":"Br J Dermatol"},{"issue":"4","key":"2025112606022239300_ski2472-bib-0045","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jaad.2008.07.001","article-title":"Medical treatments for male and female pattern hair loss","volume":"59","author":"Rogers","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"2025112606022239300_ski2472-bib-0046","author":"Barranco","year":"2010","journal-title":"Pharmaceutical formula for treating skin disease"},{"key":"2025112606022239300_ski2472-bib-0047","author":"Maniga","year":"2011","journal-title":"Minoxidil composition and non-aerosol, non-spray foam method of delivery therefor"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/6\/ski2.472\/61412258\/skinhd_4_6_e472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/6\/ski2.472\/61412258\/skinhd_4_6_e472.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T11:02:32Z","timestamp":1764154952000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/doi\/10.1002\/ski2.472\/7950867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,24]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,11,24]]},"published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ski2.472","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,11,24]]},"article-number":"ski2.472"}}